References
- Borison R. L., Moshaim A. D., Sabelli H. C. Brain 2‐phenylethylamine as a major mediator of the central actions of amphetamine and methylphenidate. Life Sciences 1975; 17: 1331–1343
- Braestrup C., Scheel‐Krüger J. Methylphenidate‐like effects of the new antidepressant drug nomifensine. European Journal of Pharmacology 1976; 38: 305–312
- Brase D. A., Loh H. H. The increase in brain tryptophan caused by amphetamine‐like drugs: Correlation with an increase in brain tryptophan. Life Sciences 1976; 18: 115–121
- Hyttel J. Inhibition of H3‐DA accumulation in rat striatal synaptosomes by psychotropic drugs. Biochemical Pharmacology 1978; 27: 1063–1068
- Oettinger L., Majovski L. V. Methylphenidate: A review. Southern Medical Journal 1976; 69: 161–163
- Pearl R. G., Seiden L. S. The existence of tolerance to and cross‐tolerance between d‐amphetamine and methylphenidate for their effects on milk consumption and on differential‐reinforcement‐of‐low‐rate performance in the rat. Journal of Pharmacology and Experimental Therapeutics 1976; 198: 635–647
- Ross S. B. On the mode of action of central stimulatory agents. Acta Pharmacologia 1977; 41: 392–396
- Yehuda S. Effects of specific brain lesions on the thermal responses of rats to d‐amphetamine. Journal of Neuroscience Research 1976; 2: 31–38
- Yehuda S. “Indirect evidence for a feedback loop mechan” ism between two central dopaminergic pathways: Preliminary results. Communications in Psycho‐pharmacology 1979; 3: 115–119
- Yehua S., Frommer R. Effects of d‐amphetamine on the set point of the thermoregulatory system in rats. Psychopharmacology 1978; 57: 249–252
- Yehuda S., Wurtman R. J. Release of brain dopamine as a probable mechanism for the hypothermic effects of d‐amphetamine. Nature 1972; 240: 477–478
- Yehuda S., Wurtman R. J. Dopaminergic neurons in the nigrostriatal and mesolimbic pathways: Mediation of specific effects of d‐amphetamine. European Journal of Pharmacology 1975; 30: 154–158